Bacterial biofilms are complex microbial communities encased in extracellular polymers.
Their formation is a multi-step process. Biofilms are a significant problem in treating bacterial …

Antibiotic resistance among Helicobacter pylori strains is the major cause of eradication
failure. Resistance prevalence is dynamic and can greatly vary among countries over the …

The global prevalence of Helicobacter pylori (H. pylori) infection remains high, indicating a
persistent presence of this pathogenic bacterium capable of infecting humans. This review …

Helicobacter pylori is considered one of the most prevalent human pathogenic microbes
globally. It is the main cause of a number of gastrointestinal ailments, including peptic and …

Biofilms and intracellular survival tremendously help Helicobacter pylori (H. pylori) escape
from antibacterial agents attacking, therefore issuing extreme challenges to clinical …

Modifying and transforming natural antibacterial products is a novel idea for developing new
efficacious compounds. Phillygenin has an inhibitory effect on H. pylori. The aim of the …

Helicobacter pylori (H. pylori) infection has been the leading cause of gastric cancer
development. In recent years, the resistance of H. pylori against antibiotic treatment has …

Peptic ulcer disease (PUD) is one of the most prevalent gastro intestinal disorder which
often leads to painful sores in the stomach lining and intestinal bleeding. Untreated …

The main goal of treating any Helicobacter pylori (H. pylori)-related gastrointestinal disease
is completely eradicating infection. Falling eradication efficiency, off-target effects, and …

Helicobacter pylori (H. pylori) is the main cause of gastric diseases. However, the traditional
antibiotic treatment of H. pylori is limited due to increased antibiotic resistance, low efficacy …